The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling
Authors
Keywords
-
Journal
CELL CYCLE
Volume 13, Issue 23, Pages 3750-3758
Publisher
Informa UK Limited
Online
2015-01-01
DOI
10.4161/15384101.2014.965068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling
- (2015) Grazia Saturno et al. Oncotarget
- Regulation of the Src-PP2A Interaction in Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis
- (2013) Jing Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors
- (2012) Hairong Cheng et al. CELL CYCLE
- Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells
- (2011) Juan Wang et al. CELL CYCLE
- Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells
- (2010) Jing Xu et al. PLoS One
- TRAIL as a target in anti-cancer therapy
- (2009) Gen Sheng Wu CANCER LETTERS
- Serine/Threonine Phosphatases: Mechanism through Structure
- (2009) Yigong Shi CELL
- Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling
- (2009) Zhaoyu Jin et al. CELL
- Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
- (2009) C. H. Mom et al. CLINICAL CANCER RESEARCH
- Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study
- (2009) Stephen Leong et al. JOURNAL OF CLINICAL ONCOLOGY
- α4 Is an Essential Regulator of PP2A Phosphatase Activity
- (2009) Mei Kong et al. MOLECULAR CELL
- Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms
- (2009) Jie Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
- (2008) Monzur Rahman et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of PP2A as a crucial regulator of the NF-κB feedback loop: its inhibition by UVB turns NF-κB into a pro-apoptotic factor
- (2008) S Barisic et al. CELL DEATH AND DIFFERENTIATION
- Cullin-RING ubiquitin ligases: global regulation and activation cycles
- (2008) Dimple R Bosu et al. Cell Division
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now